Spectrum Wealth Counsel’s AbbVie ABBV Stock Holding History

Spectrum Wealth Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$7.04M	Buy	33,604 +327	+1%	+$63.6K	0.85%	40
2024 Q4	$5.91M	Sell	33,277 -267	-0.8%	-$49.1K	0.69%	41
2024 Q3	$6.62M	Sell	33,544 -1,700	-5%	-$317K	0.78%	37
2024 Q2	$6.05M	Sell	35,244 -1,996	-5%	-$331K	0.76%	38
2024 Q1	$6.78M	Sell	37,240 -158	-0.4%	-$27.2K	0.83%	38
2023 Q4	$5.8M	Buy	+37,398	New	+$5.45M	0.8%	36

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Spectrum Wealth Counsel's ABBV Position: Q1 2025 in Review

Spectrum Wealth Counsel increased its AbbVie (ABBV) stake by 0.98% in Q1 2025, buying an estimated $63.6K and bringing the position to 33,604 shares worth $7.04M. The position accounts for 0.85% of the portfolio, ranked #40.

Spectrum Wealth Counsel first reported a position in ABBV in Q4 2023 and has held it in 6 quarters since. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Spectrum Wealth Counsel held 33,604 shares of AbbVie worth $7.04M as of Q1 2025.
Spectrum Wealth Counsel bought 327 AbbVie shares in Q1 2025, an estimated $63.6K.
AbbVie made up 0.85% of Spectrum Wealth Counsel's portfolio in Q1 2025, its #40 holding.
Spectrum Wealth Counsel first reported a position in AbbVie in Q4 2023 and has held it in 6 quarters since.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Spectrum Wealth Counsel's 13F filing for Q1 2025, filed 7 May 2025.